Noriko Okudaira
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Pharmacological Effects and Toxicity Studies, Pharmacogenetics and Drug Metabolism, Hepatitis C virus research, Computational Drug Discovery Methods
Most-Cited Works
- → A Study of the Intestinal Absorption of an Ester-Type Prodrug, ME3229, in Rats: Active Efflux Transport as a Cause of Poor Bioavailability of the Active Drug(2000)40 cited
- → Lack of Improvement of Oral Absorption of ME3277 by Prodrug Formation Is Ascribed to the Intestinal Efflux Mediated by Breast Cancer Resistant Protein (BCRP/ABCG2)(2005)28 cited
- → Polarized Efflux of Mono- and Diacid Metabolites of ME3229, an Ester-Type Prodrug of a Glycoprotein IIb/IIIa Receptor Antagonist, in Rat Small Intestine(2000)17 cited
- → The Possible Mechanism of Idiosyncratic Lapatinib-Induced Liver Injury in Patients Carrying Human Leukocyte Antigen-DRB1*07:01(2015)11 cited
- → Effect of Ion Suppression on Judgment of Enzyme Inhibition and Avoidance of Error by Utilizing a Stable Isotope-labeled Probe Substrate: Example of CYP3A4 Inhibition with [13C415N] Labeled Midazolam as a Substrate(2007)6 cited
- → Use of an Isolated Perfused Kidney to Assess Renal Clearance of Drugs(1996)5 cited
- → Contribution of intestinal transporters to drug absorption and the implications for drug discovery and development (1) : influx transporters(2006)2 cited
- → Contribution of intestinal transporters to drug absorption and the implications for drug discovery and development (2) : efflux transporters(2006)1 cited
- → Antithrombotic effects of continuous infusion of ME3277, a novel GPIIb/IIIa antagonist, in thrombosis models.(1999)
- → INTESTINAL ABSORPTION OF AN ESTER-TYPE PRODRUG, ME3229 —STUDIES ON THE EFFLUX OF METABOLITES FORMED IN THE ENTEROCYTES INTO THE GUT LUMEN—(1999)